Market Place
Sourcing Support
Torqur Partners With Lonza For Advanced Stage Development
01 Apr 2026 //
INDPHARMAPOST
Lonza Shakes Off Capsule Business In $3B Deal With Lone Star
07 Mar 2026 //
FIERCE PHARMA
Lonza Boosts Bioconjugate Innovation With Improved Synthesis
21 Feb 2026 //
INDPHARMAPOST
Lonza`s Synaffix, Sidewinder Ink ADC License Deal
07 Jan 2026 //
PR NEWSWIRE
Lonza Completes Drug Filling Line In Stein, Switzerland
08 Oct 2025 //
CONTRACTPHARMA
Lonza Expands Cell And Gene Therapy Portfolio
06 Oct 2025 //
PRESS RELEASE
Lonza`s Synaffix Partners Qurient Therapeutics For Dual-Payload
25 Sep 2025 //
PR NEWSWIRE
RION Engages Lonza for Scaling Exosome Based Therapeutics
23 Sep 2025 //
BUSINESSWIRE
Lonza Reports Sales Rebound, Samsung Bio Continues Growth
23 Jul 2025 //
FIERCE PHARMA
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines
07 Apr 2025 //
CONTRACTPHARMA
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101
11 Mar 2025 //
PRESS RELEASE
Iconovo & Lonza to collaborate on formulation development
13 Jan 2025 //
INDPHARMAPOST
Lonza`s Synaffix adds Boehringer to partners it with $1.3B ADC pact
10 Jan 2025 //
FIERCE BIOTECH
Synaffix Licenses Click Chemistry To Illumina For DNA Sequencing
04 Dec 2024 //
PR NEWSWIRE
Lonza Announces First GMP Batch Completion at US Mammalian Facility
25 Nov 2024 //
INDPHARMAPOST
Swiss CDMO Lonza widens its ADC digs with 2028 expansion
13 Nov 2024 //
FIERCE PHARMA
Lonza’s Synaffix Partners with BigHat for ML-Designed ADC
05 Nov 2024 //
INDPHARMAPOST
Lonza Completes Acquisition of Biologics Site from Roche
01 Oct 2024 //
CONTRACT PHARMA
Lonza Completes Microbial Manufacturing Expansion in Visp
05 Sep 2024 //
CONTRACT PHARMA
TriLink, Lonza In License Deal For CleanCap® mRNA Technology
30 Apr 2024 //
BUSINESSWIRE
NeuroSense, Lonza Partner On Exosome Biomarkers, Neurodegeneration
09 Apr 2024 //
PR NEWSWIRE
Lonza Signs Agreement to Acquire Large-Scale Biologics from Roche
20 Mar 2024 //
PRESS RELEASE
Lonza to buy large biologics site from Roche in US for $1.2 bln
20 Mar 2024 //
REUTERS
Lonza’s forecast for gene therapies points to uncertainty about sector`s future
19 Oct 2023 //
ENDPTS
Lonza expands antibody-drug conjugate pact, plots 180 hires
05 Oct 2023 //
FIERCE PHARMA
Catalent poaches Lonza`s David McErlane to head up biologics
18 Sep 2023 //
FIERCE PHARMA
Lonza, Vertex Break Ground for Cell Therapy Mfg. Facility
31 Aug 2023 //
CONTRACT PHARMA
Lonza cites biotech funding slowdown as it lowers sales outlook for the year
21 Jul 2023 //
ENDPTS
Vertex and Lonza team up on new cell therapy production plant
26 Jun 2023 //
FIERCE BIOTECH
Lonza Acquires Synaffix for €100M
01 Jun 2023 //
CONTRACT PHARMA
Lonza, ABL Bio Partner to Develop and Manufacture Bispecific Antibody Product
04 Apr 2023 //
CONTRACT PHARMA
Simris Alg AB, Lonza Partner to Promote ADC Payload Technology
10 Mar 2023 //
CONTRACT PHARMA
Lonza signs manufacturing agreement with Oasmia for ovarian cancer drug
22 Mar 2022 //
REUTERS
